Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
MHRA-approved options for weight management in the UK include semaglutide 2.4 mg (Wegovy), tirzepatide (Mounjaro), orlistat, and naltrexone/bupropion (Mysimba), with eligibility criteria varying by treatment
Quick start with a common peptide: Usama is Analytic Chemist Expert, 3+ years experience in known Quality Control Labs, holding degree of BS (Hons) Chemistry from University of Education
It is designed for adults living with obesity who have already been using the standard 2.4 mg maintenance dose for at least 4 weeks and would benefit from additional weight loss support
As of July 2026, Hers requires a weight loss membership, which costs $39 for your first month and renews at $149 per month, billed separately from the medication itself
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
With off-label use, doctors prescribe a drug for a purpose other than what its approved for
:max_bytes(150000):strip_icc()/VWH-GettyImages-2275860768-a6f6e63304e048d0a829844c1dacbd8d.jpg)
US$ 20.74
US$ 25.76
US$ 24.85
US$ 23.52
US$ 27.94
